HCA Healthcare, Inc. $HCA Shares Sold by Mondrian Investment Partners LTD

Mondrian Investment Partners LTD trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 99.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,389 shares of the company’s stock after selling 248,741 shares during the period. Mondrian Investment Partners LTD’s holdings in HCA Healthcare were worth $648,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of HCA. National Pension Service increased its holdings in shares of HCA Healthcare by 2.9% in the 3rd quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after acquiring an additional 17,531 shares during the period. Savant Capital LLC increased its holdings in shares of HCA Healthcare by 37.7% in the 3rd quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after acquiring an additional 1,246 shares during the period. Nordea Investment Management AB increased its holdings in shares of HCA Healthcare by 11.2% in the 4th quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock worth $507,393,000 after acquiring an additional 108,849 shares during the period. Sector Gamma AS increased its holdings in shares of HCA Healthcare by 36.0% in the 3rd quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock worth $4,638,000 after acquiring an additional 2,883 shares during the period. Finally, AlphaQuest LLC grew its position in HCA Healthcare by 2,855.2% in the 3rd quarter. AlphaQuest LLC now owns 5,999 shares of the company’s stock valued at $2,557,000 after buying an additional 5,796 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Up 0.5%

NYSE:HCA opened at $394.40 on Friday. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The company has a 50-day moving average of $465.16 and a 200-day moving average of $483.61. The firm has a market cap of $87.49 billion, a price-to-earnings ratio of 13.56, a price-to-earnings-growth ratio of 1.25 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same quarter in the previous year, the business earned $6.45 earnings per share. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of recent analyst reports. Sanford C. Bernstein decreased their target price on shares of HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating for the company in a research report on Tuesday, April 28th. Weiss Ratings lowered shares of HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, May 18th. UBS Group increased their target price on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a research report on Monday, February 23rd. TD Cowen decreased their target price on shares of HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, April 27th. Finally, Barclays decreased their target price on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $515.77.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.